Latest Whitepapers

Alzheimer’s disease (AD) is the most common form of dementia, and it is also one of the most common neurodegenerative diseases. AD comes with memory impairments, and as a result many of the neurobehavioral studies done on AD involve the water maze test.

Download this whitepaper to learn more about how dilutional linearity enhances reliability, undetected HCP can be minimized as well as consistently low variation ensures reproducible data.

Download this whitepaper to discover how a cell sorter can provide precise sorting while maintaining low droplet charge voltages and also handle very high event and sort rates.

Download this whitepaper to learn more about antibody engineering design parameters, different options including humanization and fragments as well as the future of antibody engineering.

Download this whitepaper to discover how LC-MS can deliver unmatched analyte specificity for antibody-drug conjugates with high-throughput analyses and is useful in product development.

Learn about the focus of current psychedelic research efforts and where the most promising progress is being made in this exciting area of drug discovery and development.

Vaccination is largely recognized as the most cost-effective way to fight human infectious diseases. Vaccines play a vital role in immunization strategies that have helped to eradicate dangerous pathogens, increase human life expectancy and reduce disabilities and suffering all around the world.

It is paramount within the pharmaceutical industry that scientists can manage large amounts of data efficiently and safely. The Cubis® II balance series was designed for customizable modularity, meeting the needs of the industry whilst maintaining full compliance.

Single-cell sequencing is quickly becoming a standard tool in biological research due to the scale and depth of insight it provides across diverse cell populations. The pharmaceutical industry is exploiting single-cell approaches to identify novel therapeutic targets and accelerate promising assets through development.

Access this whitepaper to discover a system that performs virtual screening at ultra-high-throughput scale, requires minimal costs and can be run with cloud computing or HPC resources.